Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanping Zhang

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 4, 2021
Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy aloneYunzhu Dai, Yuanping Zhang, Wei He, et al.
Cell Death & Disease|August 4, 2022
NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3Yuanping Zhang, Dinglan Zuo, Jiliang Qiu, et al.
Cancer Communications (London, England)|May 23, 2018
Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort studyWei He, Yun Zheng, Ruhai Zou, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2018
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysisWenwu Liu, Yun Zheng, Wei He, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular CarcinomaBinkui Li, Jiliang Qiu, Yun Zheng, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching studyChenwei Wang, Yadi Liao, Jiliang Qiu, et al.
Annals of Translational Medicine|September 21, 2020
Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary studyWei He, Leen Liao, Dandan Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 26, 2019
Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomyChenwei Wang, Wei He, Yichuan Yuan, et al.
Digestive Surgery|November 5, 2020
Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation TherapyYongjin Wang, Yadi Liao, Wenwu Liu, et al.
Plos One|September 7, 2012
Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosisQinxiang Zheng, Yueping Ren, Radouil Tzekov, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 4, 2021
Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy aloneYunzhu Dai, Yuanping Zhang, Wei He, et al.
Cell Death & Disease|August 4, 2022
NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3Yuanping Zhang, Dinglan Zuo, Jiliang Qiu, et al.
Cancer Communications (London, England)|May 23, 2018
Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort studyWei He, Yun Zheng, Ruhai Zou, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2018
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysisWenwu Liu, Yun Zheng, Wei He, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular CarcinomaBinkui Li, Jiliang Qiu, Yun Zheng, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching studyChenwei Wang, Yadi Liao, Jiliang Qiu, et al.
Annals of Translational Medicine|September 21, 2020
Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary studyWei He, Leen Liao, Dandan Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 26, 2019
Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomyChenwei Wang, Wei He, Yichuan Yuan, et al.
Digestive Surgery|November 5, 2020
Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation TherapyYongjin Wang, Yadi Liao, Wenwu Liu, et al.
Plos One|September 7, 2012
Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosisQinxiang Zheng, Yueping Ren, Radouil Tzekov, et al.
Pageof 5